Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 14,490
-10 (-0.07%)
At close: Aug 21, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 33.43 billion as of August 21, 2026. Its market cap has increased by 7.33% in one year.
Market Cap
33.43B
Enterprise Value
n/a
Revenue
449.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
14,490.00
ChartMarket Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 33.43B, a decrease of -42.94%. That is a compound annual growth rate of -16.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 33.43B | -3.40% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KoBioLabs | 58.26B |
| J2KBIO | 51.17B |
| Parataxis Korea | 44.13B |
| HLB Pep | 43.60B |
| Progen | 40.36B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Quratis | 32.72B |